Related Experiment Video
Updated: Dec 14, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Acute Cerebrovascular Events in Hospitalized COVID-19 Patients
Aaron Rothstein1, Olivia Oldridge1, Hannah Schwennesen1
1Department of Neurology, University of Pennsylvania, Philadelphia.
Insights
This study found a low incidence of stroke in hospitalized coronavirus disease 2019 (COVID-19) patients. Most strokes were linked to traditional risk factors and common mechanisms, not solely COVID-19.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Initial reports indicated a heightened risk of thrombotic events, including stroke, in patients with coronavirus disease 2019 (COVID-19).
- Limited systematic data exists on stroke incidence and mechanisms, particularly within diverse U.S. populations.
- Understanding stroke risk in COVID-19 is crucial for patient management and public health strategies.
Purpose of the Study:
- To investigate the incidence and mechanisms of stroke in hospitalized patients with COVID-19.
- To analyze stroke characteristics in a racially diverse patient cohort.
- To identify potential risk factors and stroke etiologies associated with COVID-19 hospitalization.
Main Methods:
- A retrospective, observational study was conducted.
- Data was collected from 844 hospitalized COVID-19 patients across three Philadelphia hospitals between March 15 and May 3, 2020.
- Stroke incidence, mechanisms, patient demographics, and vascular risk factors were analyzed.
Main Results:
- 2.4% of COVID-19 patients experienced ischemic stroke, and 0.9% had intracranial hemorrhage.
- The majority of ischemic stroke patients were Black, older, and had pre-existing hypertension and diabetes.
- Newly positive antiphospholipid antibodies were observed in over 75% of tested patients; cardioembolism was the most common stroke mechanism.
Conclusions:
- The risk of acute cerebrovascular events in hospitalized COVID-19 patients was found to be low.
- Conventional vascular risk factors and traditional stroke mechanisms predominated in patients who experienced stroke.
- Further research is needed to fully elucidate the complex relationship between COVID-19 and cerebrovascular events.
Background And Purpose:
Initial reports suggest a significant risk of thrombotic events, including stroke, in patients hospitalized with coronavirus disease 2019 (COVID-19). However, there is little systematic data on stroke incidence and mechanisms, particularly in racially diverse populations in the United States.
Methods:
We performed a retrospective, observational study of stroke incidence and mechanisms in all patients with COVID-19 hospitalized from March 15 to May 3, 2020, at 3 Philadelphia hospitals.
Results:
We identified 844 hospitalized patients with COVID-19 (mean age 59 years, 52% female, 68% Black); 20 (2.4%) had confirmed ischemic stroke; and 8 (0.9%) had intracranial hemorrhage. Of the ischemic stroke patients, mean age was 64 years, with only one patient (5%) under age 50, and 80% were Black. Conventional vascular risk factors were common, with 95% of patients having a history of hypertension and 60% a history of diabetes mellitus. Median time from onset of COVID symptoms to stroke diagnosis was 21 days. Stroke mechanism was cardioembolism in 40%, small vessel disease in 5%, other determined mechanism in 20%, and cryptogenic in 35%. Of the 11 patients with complete vascular imaging, 3 (27%) had large vessel occlusion. Newly positive antiphospholipid antibodies were present in >75% of tested patients. Of the patients with intracranial hemorrhage, 5/8 (63%) were lobar intraparenchymal hemorrhages, and 3/8 (38%) were subarachnoid hemorrhage; 4/8 (50%) were on extracorporeal membrane oxygenation.
Conclusions:
We found a low risk of acute cerebrovascular events in patients hospitalized with COVID-19. Most patients with ischemic stroke had conventional vascular risk factors, and traditional stroke mechanisms were common.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

